Literature DB >> 27347789

BMI history and risk of incident fatty liver: a population-based large-scale cohort study.

Yoshitaka Hashimoto1, Masahide Hamaguchi, Takuya Fukuda, Naoto Nakamura, Akihiro Ohbora, Takao Kojima, Michiaki Fukui.   

Abstract

BACKGROUND AND AIMS: Most physicians might consider that fatty liver would develop along with increasing body weight; however, an association between BMI history and incident fatty liver has not been clarified as yet.
METHODS: We carried out a population-based cohort study that included 4427 healthy Japanese individuals who received yearly health-checkup programs over a decade. Fatty liver was diagnosed using ultrasonography.
RESULTS: During the observational period, 38.7% (case/N=1002/2588) of men and 17.3% (319/1847) of women were diagnosed with fatty liver. Among these, only 18.9% (189 of 1002 participants) of men and 18.5% (59 of 319) of women developed fatty liver when they reached the lifetime maximum BMI. Adjusted odds ratio of the difference between lifetime maximum BMI and BMI at age 20 years (ΔBMImax-20 years) for incident fatty liver was 1.33 [95% confidence interval (CI) 1.28-1.39, P<0.001] in men or 1.40 (95% CI 1.33-1.49, P<0.001) in women. According to receiver operator characteristic (ROC) analysis, the optimal cut-off points of ΔBMImax-20 years for incident fatty liver were 4.82 kg/m [area under ROC curve 0.70 (95% CI 0.68-0.72), P<0.001] in men and 4.11 kg/m [area under ROC curve 0.76 (95% CI 0.73-0.79), P<0.001] in women.
CONCLUSION: The ΔBMImax-20 years was associated with an increased risk of incident fatty liver. In addition, more patients developed fatty liver not at the maximum point of BMI history, but after that. Therefore, it is useful to check ΔBMImax-20 years and to continue observing the individuals for detection of fatty liver.

Entities:  

Mesh:

Year:  2016        PMID: 27347789     DOI: 10.1097/MEG.0000000000000682

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  10 in total

1.  Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals.

Authors:  Yoshitaka Hashimoto; Masahide Hamaguchi; Takuya Fukuda; Akihiro Ohbora; Takao Kojima; Michiaki Fukui
Journal:  Endocrine       Date:  2017-05-16       Impact factor: 3.633

2.  Clinical Significance of Lifetime Maximum Body Mass Index in Predicting the Development of T2DM: A Prospective Study in Beijing.

Authors:  Xiaomeng Jia; Anping Wang; Longyan Yang; Yu Cheng; Yajing Wang; Jianming Ba; Jingtao Dou; Yiming Mu; Dong Zhao; Zhaohui Lyu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-02       Impact factor: 6.055

3.  Weight gain since age of 20 as risk of metabolic syndrome even in non-overweight individuals.

Authors:  Yoshitaka Hashimoto; Masahide Hamaguchi; Takuya Fukuda; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  Endocrine       Date:  2017-09-30       Impact factor: 3.633

Review 4.  Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV.

Authors:  Amedeo Lonardo; Stefano Ballestri; Giovanni Guaraldi; Fabio Nascimbeni; Dante Romagnoli; Stefano Zona; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

5.  Association between physical activity and risk of nonalcoholic fatty liver disease: a meta-analysis.

Authors:  Shanhu Qiu; Xue Cai; Zilin Sun; Ling Li; Martina Zügel; Jürgen Michael Steinacker; Uwe Schumann
Journal:  Therap Adv Gastroenterol       Date:  2017-08-25       Impact factor: 4.409

6.  Adiposity in relation to risks of fatty liver, cirrhosis and liver cancer: a prospective study of 0.5 million Chinese adults.

Authors:  Yuanjie Pang; Christiana Kartsonaki; Iain Turnbull; Yu Guo; Yiping Chen; Robert Clarke; Zheng Bian; Fiona Bragg; Iona Y Millwood; Ling Yang; Ying Huang; Yan Yang; Xukui Zhang; Junshi Chen; Liming Li; Michael V Holmes; Zhengming Chen
Journal:  Sci Rep       Date:  2019-01-28       Impact factor: 4.379

7.  The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.

Authors:  Aya Kitae; Yoshitaka Hashimoto; Masahide Hamaguchi; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  Can J Gastroenterol Hepatol       Date:  2019-10-07

8.  Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study.

Authors:  Takuro Okamura; Yoshitaka Hashimoto; Masahide Hamaguchi; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  BMJ Open Diabetes Res Care       Date:  2020-09

9.  Eating Fast Is Associated with Nonalcoholic Fatty Liver Disease in Men But Not in Women with Type 2 Diabetes: A Cross-Sectional Study.

Authors:  Fuyuko Takahashi; Yoshitaka Hashimoto; Rena Kawano; Ayumi Kaji; Ryosuke Sakai; Yuka Kawate; Takuro Okamura; Emi Ushigome; Noriyuki Kitagawa; Saori Majima; Takafumi Sennmaru; Hiroshi Okada; Naoko Nakanishi; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  Nutrients       Date:  2020-07-22       Impact factor: 5.717

10.  Reduction of Fat to Muscle Mass Ratio Is Associated with Improvement of Liver Stiffness in Diabetic Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Takafumi Osaka; Yoshitaka Hashimoto; Takuro Okamura; Takuya Fukuda; Masahiro Yamazaki; Masahide Hamaguchi; Michiaki Fukui
Journal:  J Clin Med       Date:  2019-12-09       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.